Apotex Corp. v. Hospira Healthcare India Private Limited

Filing 126

ORDER: granting 125 Letter Motion for Extension of Time to File. Application GRANTED. The deadline to submit supplemental briefs is hereby EXTENDED to January 24, 2020. The Clerk of Court is directed to terminate ECF No. 125. SO ORDERED. (Signed by Judge Jesse M. Furman on 1/16/2020) (ama)

Download PDF
WENDY ZORANA ZUPAC (202) 434-5231 wzupac@wc.com January 15, 2020 VIA CM/ECF Application GRANTED. The deadline to submit supplemental briefs is hereby EXTENDED to January 24, 2020. The Clerk of Court is directed to terminate ECF No. 125. SO ORDERED. The Honorable Jesse M. Furman United States District Judge Thurgood Marshall United States Courthouse 40 Foley Square New York, NY 10007 Re: January 16, 2020 Apotex Corp. v. Hospira Healthcare India Private Limited and Hospira Inc., No. 18-CV-4903 (JMF) Dear Judge Furman, Plaintiff Apotex Corp. (“Apotex”) and Defendants Hospira Healthcare India Private Limited and Hospira, Inc. (“Hospira”, and with Apotex, the “Parties”) jointly submit this lettermotion respectfully to request that the Court extend the deadline for the Parties to submit supplemental briefs on whether the Court should exercise supplemental jurisdiction over the remaining state-law claims until January 24, 2020. On January 6, 2020, this Court issued an Opinion and Order granting Hospira’s motion to dismiss Apotex’s monopolization and attempted monopolization claims under Section 2 of the Sherman Antitrust Act, 15 U.S.C. § 2. See Dkt. No. 124. Under 28 U.S.C. § 1367, the Court has discretion whether to exercise supplemental jurisdiction over the remaining state law claims, and the Court ordered the Parties to submit supplemental briefs (not to exceed five pages) addressing this issue by January 17, 2020. Id. At the time the Court issued its Order, senior counsel for the Parties were in Melbourne, Australia, conducting depositions in this matter. Counsel did not return to the United States until Sunday, January 12, 2020. In light of these depositions and resulting travel, both Parties respectfully request an additional week to submit the supplemental briefs, such that the briefs would be due on Friday, January 24, 2020. Counsel for the Parties have not previously requested an extension of time to submit this briefing. The Parties are next scheduled to appear before this Court for a pretrial conference on October 27, 2020. January 15, 2020 Page 2 Respectfully submitted, /s/ Sara P. Madavo (by consent) Sara P. Madavo Foley & Lardner LLP 90 Park Avenue New York, New York 10016 Telephone: (212) 338-3626 Facsimile: (212) 682-2329 Email: smadavo@foley.com /s/ Wendy Z. Zupac Wendy Z. Zupac Williams & Connolly LLP 725 12th St. NW Washington, DC 20005 Telephone: (202) 434-5000 Facsimile: (202) 434-5029 Email: wzupac@wc.com Counsel for Plaintiff Apotex Corp. Counsel for Defendants Hospira Healthcare India Private Limited and Hospira, Inc. Encl. Cc: All counsel of record

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?